Diasorin LIAISON Measles IgG - HSA Registration DE0507554
Access comprehensive regulatory information for Diasorin LIAISON Measles IgG in the Singapore medical device market through Pure Global AI's free database. This CLASS C IVD medical device is registered under HSA registration number DE0507554 and owned by DiaSorin Italia S.p.A.. The device was registered on November 29, 2022.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The LIAISON® Measles IgG assay uses chemiluminescence immunoassay (CLIA) technology for the semi- quantitative determination of specific IgG antibodies to measles virus in human serum samples. It is intended to be used as an aid in the determination of serological status to measles virus. The test has to be performed on the LIAISON® Analyzer family.